SITC's World Immunotherapy Council's Young Investigator Symposium
The World Immunotherapy Council (WIC) is a global initiative led by the Society for Immunotherapy of Cancer (SITC). It brings together 18 organizations dedicated to advancing cancer immunotherapy research and its translation into clinical practice. The goal of the WIC is to foster scientific exchange and global collaboration to accelerate the development and delivery of new immunotherapies to patients worldwide.
As a member society of the WIC, the CCIC is honoured to participate in the WIC Young Investigator Symposium, which takes place every two years during the SITC's Annual Meeting. CCIC nominates an outstanding young investigator to represent Canada at this prestigious international forum.
The WIC Young Investigator Symposium provides a valuable platform for emerging scientists and future leaders from around the world to engage in scientific exchange and contribute to the advancement of cancer immunotherapy. Each nominated investigator, selected for exemplary work in the field, shares insight into current challenges, innovations, and future directions as immunotherapies continue to transform cancer treatment.
This forum highlights worldwide initiatives in cancer immunotherapy and facilitates scientific exchange and networking among today’s and tomorrow’s leaders. It also offers a unique opportunity to showcase the next generation of talented scientists, promoting knowledge exchange and fostering future international collaborations.
As a member society of the WIC, the CCIC is honoured to participate in the WIC Young Investigator Symposium, which takes place every two years during the SITC's Annual Meeting. CCIC nominates an outstanding young investigator to represent Canada at this prestigious international forum.
The WIC Young Investigator Symposium provides a valuable platform for emerging scientists and future leaders from around the world to engage in scientific exchange and contribute to the advancement of cancer immunotherapy. Each nominated investigator, selected for exemplary work in the field, shares insight into current challenges, innovations, and future directions as immunotherapies continue to transform cancer treatment.
This forum highlights worldwide initiatives in cancer immunotherapy and facilitates scientific exchange and networking among today’s and tomorrow’s leaders. It also offers a unique opportunity to showcase the next generation of talented scientists, promoting knowledge exchange and fostering future international collaborations.
Nominated CCIC Representatives
Meet the nominated young investigators to represent CCIC and share their research at the WIC Young Investigator Symposium:
|
|
|
|
2025 - Michael Geuenich
Lunenfeld-Tanenbaum Research Institute Presentation: "Deciphering the clinical and molecular determinants of tertiary lymphoid structure heterogeneity in pancreatic cancer by integrating multimodal spatial transcriptomics, proteomics, and histopathology imaging" |
2023 - Anirban Das
The Hospital for Sick Children Presentation: "Combined immunotherapy improves outcome for replication repair deficient (RRD) high grade glioma failing anti-PD1 monotherapy: a report from the international RRD Consortium" |
2021 - Adam Nelson
Dalhousie University Presentation: "Combination of NKT cell immunotherapy and oncolytic vesicular stomatitis virus expressing FAST proteins clears metastatic triple negative breast cancer" |
2019 - Diana Canals
University of British Columbia Presentation: "Podocalyxin is a Therapeutic Target in Carcinoma" |
2017 - Sarah Crome
Princess Margaret Cancer Center Presentation: "A novel innate lymphoid cell population regulates tumor-associated T cells" |
2015 - Julie Nielsen
BC Cancer Agency Presentation: "Toward personalized immunotherapy for lymphoma: Identification of common driver mutations recognized by patient T cells" |
WORLD IMMUNOTHERAPY COUNCIL MEETINGS
|
|